Variant report

Variant	rs578112281
Chromosome Location	chr9:96717162-96717163
allele	C/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CHD1	chr9:96717050-96717171	H1-hESC	embryonic stem cell:	n/a	n/a
2	SUZ12	chr9:96709708-96717433	H1-hESC	embryonic stem cell:	n/a	n/a
3	POLR2A	chr9:96716169-96718368	Hela-S3	cervix:	n/a	n/a
4	MAX	chr9:96716327-96717225	H1-hESC	embryonic stem cell:	n/a	n/a
5	E2F6	chr9:96716184-96717258	H1-hESC	embryonic stem cell:	n/a	chr9:96717156-96717171 chr9:96716525-96716533 chr9:96716525-96716533 chr9:96716808-96716818 chr9:96717160-96717172 chr9:96716526-96716533 chr9:96716848-96716858 chr9:96716519-96716529 chr9:96716524-96716534
6	MAX	chr9:96716412-96717217	H1-hESC	embryonic stem cell:	n/a	n/a
7	MAX	chr9:96716821-96717314	A549	lung:	n/a	n/a
8	CTBP2	chr9:96710652-96717425	H1-hESC	embryonic stem cell:	n/a	n/a
9	E2F6	chr9:96716852-96717262	H1-hESC	embryonic stem cell:	n/a	chr9:96717156-96717171 chr9:96717160-96717172

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr9:96709646..96715968-chr9:96715980..96721050,10	MCF-7	breast:

Variant related genes	Relation type
BARX1	TF binding region
ENSG00000235601	TF binding region
ENSG00000131668	Chromatin interaction

Extended variants
information (count: 5 )
Associated
traits (count: 0)

Variant overlapped rSNPs/rCNVs (count:5 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv893589	chr9:96624645-96884544	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
2	nsv824993	chr9:96699362-96725105	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Weak transcription Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	4 gene(s)	inside rSNPs	diseases
3	nsv893590	chr9:96701287-96729129	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Weak transcription ZNF genes & repeats Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	4 gene(s)	inside rSNPs	diseases
4	esv3442102	chr9:96716156-96718704	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	diseases
5	esv3412213	chr9:96716656-96718704	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:69 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:96713800-96717200	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
2	chr9:96713800-96717400	Bivalent Enhancer	Fetal Muscle Leg	muscle
3	chr9:96713800-96717800	Bivalent Enhancer	Liver	Liver
4	chr9:96713800-96718400	Bivalent Enhancer	Lung	lung
5	chr9:96714200-96717200	Bivalent Enhancer	Primary B cells from peripheral blood	blood
6	chr9:96714200-96717400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
7	chr9:96714200-96717800	Enhancers	Pancreas	Pancrea
8	chr9:96714400-96717200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
9	chr9:96715000-96718800	Bivalent Enhancer	Spleen	Spleen
10	chr9:96715400-96717200	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
11	chr9:96715800-96717200	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
12	chr9:96715800-96717200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
13	chr9:96716000-96717200	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
14	chr9:96716000-96717400	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
15	chr9:96716200-96718200	Active TSS	Osteobl	bone
16	chr9:96716400-96717200	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
17	chr9:96716400-96717200	Flanking Bivalent TSS/Enh	Right Ventricle	heart
18	chr9:96716400-96717800	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
19	chr9:96716400-96718400	Active TSS	Hela-S3	cervix
20	chr9:96716400-96718600	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
21	chr9:96716400-96718600	Bivalent/Poised TSS	Fetal Stomach	stomach
22	chr9:96716400-96718800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
23	chr9:96716600-96717200	Flanking Bivalent TSS/Enh	Ganglion Eminence derived primary cultured neurospheres	brain
24	chr9:96716600-96717200	Active TSS	Gastric	stomach
25	chr9:96716600-96717200	Bivalent Enhancer	Left Ventricle	heart
26	chr9:96716600-96717600	Bivalent/Poised TSS	Esophagus	oesophagus
27	chr9:96716600-96717800	Bivalent Enhancer	Primary B cells from cord blood	blood
28	chr9:96716600-96717800	Bivalent/Poised TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
29	chr9:96716800-96717200	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
30	chr9:96716800-96717200	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
31	chr9:96716800-96717200	Flanking Bivalent TSS/Enh	Breast Myoepithelial Primary Cells	Breast
32	chr9:96716800-96717200	Flanking Bivalent TSS/Enh	Primary T helper naive cells fromperipheralblood	blood
33	chr9:96716800-96717200	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
34	chr9:96716800-96717200	Bivalent Enhancer	Brain Anterior Caudate	brain
35	chr9:96716800-96717400	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
36	chr9:96716800-96717800	Bivalent Enhancer	Primary hematopoietic stem cells	blood
37	chr9:96716800-96718400	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
38	chr9:96716800-96718400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
39	chr9:96716800-96718400	Active TSS	A549	lung
40	chr9:96717000-96717200	Flanking Bivalent TSS/Enh	H1 Derived Mesenchymal Stem Cells	ES cell derived
41	chr9:96717000-96717200	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
42	chr9:96717000-96717200	Bivalent/Poised TSS	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr9:96717000-96717200	Flanking Bivalent TSS/Enh	Cortex derived primary cultured neurospheres	brain
44	chr9:96717000-96717200	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
45	chr9:96717000-96717200	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
46	chr9:96717000-96717200	Flanking Bivalent TSS/Enh	Primary mononuclear cells fromperipheralblood	Blood
47	chr9:96717000-96717200	Flanking Bivalent TSS/Enh	Adipose Nuclei	Adipose
48	chr9:96717000-96717200	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
49	chr9:96717000-96717200	Flanking Bivalent TSS/Enh	Brain Hippocampus Middle	brain
50	chr9:96717000-96717200	Bivalent Enhancer	Colonic Mucosa	Colon

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links